Find in Library

699 Phase 2 trial of brentuximab vedotin (BV) with pembrolizumab (pembro) in patients with metastatic non-small cell lung cancer or metastatic cutaneous melanoma after progression on anti-PD-1 therapy

oleh: Omid Hamid, Sylvia Lee, Hailing Lu, Sunandana Chandra, Yousef Zakharia, Inderjit Mehmi, Marya Chaney, Graham Watson, Patrick Ward, Brian P O’Connor, Robert M Jotte, Amanda Gillespie-Twardy, Jason D Berndt, Kapil Rathi, Scott Knowles, Charles Cowey